Contingent Liabilities and Commitments (Tables)

12 Months Ended

Dec. 31, 2018

Commitments and Contingencies Disclosure [Abstract]

Contractual Obligation, Fiscal Year Maturity Schedule

The following table presents contractual obligations of the Company at December 31, 2018:

	Payments Due by Period
Contractual Obligations:	Total		Less than 1 Year		1 to 3 Years		3 to 5 Years		More than 5 Years
Long-term debt and interest	$	173,009	$	6,575	$	12,981	$	153,453	$	—
Long-term related party payable (undiscounted)	51,284		9,439		8,713		7,250		25,882
Purchase commitments	26,682		10,754		10,828		5,100		—
Operating leases	5,836		1,191		2,217		1,461		967
Total contractual cash obligations	$	256,811	$	27,959	$	34,739	$	167,264	$	26,849

Included in the purchase commitments total above, is approximately $15,308 of an obligation of Specialty Pharma, which on February 6, 2019, filed for Chapter 11 bankruptcy protection.

Commitments for these arrangements, at maximum quantities and at contractual prices over the remaining life of the contract, and excluding any waived commitments, are as follows for the years ended December 31:

Purchase Commitments:	Balance
2019	$	10,754
2020	5,948
2021	4,880
2022	4,880
2023	220
Thereafter	—
Total	$	26,682

Schedule of Future Minimum Rental Payments for Operating Leases

The Company and our subsidiaries lease office facilities under noncancelable operating leases expiring at various dates. Rent expense, net of rental income, was $1,213, $1,146 and $970 in 2018, 2017, and 2016, respectively. Minimum rental commitments for non-cancelable leases in effect at December 31, 2018 are as follows:

Lease Commitment:	Balance
2019	$	1,191
2020	1,208
2021	1,008
2022	767
2023	695
Thereafter	967
Total	$	5,836